Detalles de la búsqueda
1.
Short-, mid- and long-term efficacy of dupilumab in moderate to severe atopic dermatitis: a real life multicenter Italian study on 2576 patients.
Clin Exp Dermatol
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38860563
2.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis).
J Eur Acad Dermatol Venereol
; 37(1): 93-103, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156312
3.
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol
; 37(5): 1017-1027, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695061
4.
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis).
Dermatol Ther
; 35(8): e15608, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638250
5.
Real-world evidence of biologic treatments in moderate-severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study.
Dermatol Ther
; 35(1): e15166, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676662
6.
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.
J Allergy Clin Immunol
; 147(2): 558-560.e1, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33160968
7.
Can intermittent, time-restricted circadian fasting modulate cutaneous severity of dermatological disorders? Insights from a multicenter, observational, prospective study.
Dermatol Ther
; 34(3): e14912, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33629451
8.
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study.
Acta Derm Venereol
; 101(11): adv00605, 2021 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596230
9.
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.
BMC Health Serv Res
; 21(1): 924, 2021 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34488749
10.
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration.
Dermatol Ther
; 33(5): e13475, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356577
11.
COVID-19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED-ZONE declaration.
Dermatol Ther
; 33(4): e13508, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415727
12.
Predicting Secukinumab Fast-Responder Profile in Psoriatic Patients: Advanced Application of Artificial-Neural-Networks (ANNs).
J Drugs Dermatol
; 19(12): 1241-1246, 2020 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33346505
13.
From randomized clinical trials to real life data. An Italian clinical experience with ixekizumab and its management.
Dermatol Ther
; 32(3): e12886, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30942952
14.
When IL-17 inhibitors fail: Real-life evidence to switch from secukinumab to adalimumab or ustekinumab.
Dermatol Ther
; 32(2): e12793, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515970
15.
Switching from Secukinumab to Ustekinumab in Psoriasis Patients: Results from a Multicenter Experience.
Dermatology
; 235(3): 213-218, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928971
16.
Heterologous versus homologous primary and booster COVID-19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real-life, multicenter, case-control study.
J Eur Acad Dermatol Venereol
; 37(6): e693-e694, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36734591
17.
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients.
J Eur Acad Dermatol Venereol
; 37(10): e1203-e1207, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37170951
18.
Palmoplantar pustulosis successfully treated with upadacitinib: Report of three cases.
Australas J Dermatol
; 64(4): 568-570, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607109
19.
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
Dermatology
; 232(2): 230-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26678060
20.
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study.
J Am Acad Dermatol
; 81(1): 273-275, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790602